Collaborative Care Versus Screening and Follow-up for Patients With Diabetes and Depressive Symptoms: Results of a Primary Care–Based Comparative Effectiveness Trial
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Depressive symptoms are common and, when coexisting with diabetes, worsen outcomes and increase health care costs. We evaluated a nurse case-manager–based collaborative primary care team model to improve depressive symptoms in diabetic patients. RESEARCH DESIGN AND METHODS: We conducted a controlled implementation trial in four nonmetropolitan primary care networks. Eligible patients had type 2 diabetes and screened positive for depressive symptoms, based on a Patient Health Questionnaire (PHQ) score of ≥10. Patients were allocated using an “on-off” monthly time series. Intervention consisted of case-managers working 1:1 with patients to deliver individualized care. The main outcome was improvement in PHQ scores at 12 months. A concurrent cohort of 71 comparable patients was used as nonscreened usual care control subjects. RESULTS: Of 1,924 patients screened, 476 (25%) had a PHQ score >10. Of these, 95 were allocated to intervention and 62 to active control. There were no baseline differences between groups: mean age was 57.8 years, 55% were women, and the mean PHQ score was 14.5 (SD 3.7). Intervention patients had greater 12-month improvements in PHQ (7.3 [SD 5.6]) compared with active-control subjects (5.2 [SD 5.7], P = 0.015). Recovery of depressive symptoms (i.e., PHQ reduced by 50%) was greater among intervention patients (61% vs. 44%, P = 0.03). Compared with trial patients, nonscreened control subjects had significantly less improvement at 12 months in the PHQ score (3.2 [SD 4.9]) and lower rates of recovery (24%, P < 0.05 for both). CONCLUSIONS: In patients with type 2 diabetes who screened positive for depressive symptoms, collaborative care improved depressive symptoms, but physician notification and follow-up was also a clinically effective initial strategy compared with usual care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-8 as a measure of current depression in the general population
Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B. W., Berry, J. T., & Mokdad, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.026 · Cited by 5,121 · cited 2×
“One item (suicide screen) from the PHQ9 is omitted in the PHQ8, and the latter was used because no follow-up was planned for the cohort participants who might positively respond to this item.”
MethodInterim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets
van Hout, B., Janssen, M. F., Feng, Y.-S., Kohlmann, T., Busschbach, J., Golicki, D., Lloyd, A., Scalone, L., Kind, P., & Pickard, A. S. (2012) · Value in Health · doi:10.1016/j.jval.2012.02.008 · Cited by 2,153
Manea, L., Gilbody, S., & McMillan, D. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.110829 · Cited by 1,966 · cited 2×
“Although this difference is well below the previously suggested criterion (and our a priori standard) of 5 points (14,31), some controlled studies suggest that even small to moderate improvements Table 1—Baseline characteristics for trial participants”
BackgroundAssociation of depression and diabetes complications: a meta-analysis
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799 · cited 1×
“Depression itself is considered a risk factor for the development of type 2 diabetes (2) and is associated with poorer self-care behaviors (3), worse glycemic control, increased risk of complications (4), decreased quality of life (5), and substantially higher health care costs (6).”
BackgroundCollaborative care for patients with depression and chronic illnesses
Katon, W. J., Lin, E. H. B., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, B., Peterson, D., Rutter, C. M., McGregor, M., & McCulloch, D. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003955 · Cited by 1,697
Self-citationCollaborative Care for Depression: A Cumulative Meta-analysis and Review of Longer-term Outcomes
Gilbody, S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.21.2314 · Cited by 1,340
Katon (2004) · doi:10.1001/archpsyc.61.10.1042 · Cited by 737
The mental health comorbidities of diabetes
Ducat, L., Philipson, L. H., & Anderson, B. J. (2014) · JAMA · doi:10.1001/jama.2014.8040 · Cited by 402
Enhancing the clinical utility of depression screening
Kroenke, K. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.112004 · Cited by 216 · cited 4×
“We also evaluated the rates of clinically significant recovery (PHQ improved by 50% of the baseline score) and amelioration of depressive symptoms (PHQ ,10) at 12 months (14,20).”
BackgroundMethodInfluentialAli, S., Stone, M., Skinner, T. C., Robertson, N., Davies, M., & Khunti, K. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1065 · Cited by 186
Cited by
van der Feltz‐Cornelis, C., Allen, S. F., Holt, R. I. G., Roberts, R., Nouwen, A., & Sartorius, N. (2021) · Brain and Behavior · doi:10.1002/brb3.1981 · Cited by 130
“MDD Yes No Comparison of different pharmacological agents (6 RCTs, comparative effectiveness trials (CETs) n = 291) Gülseren et al. (2005) Turkey n = 23 Type 2 DM 100% 58.2–57.1 ± 12.3– 10.4 MDD according to SCID, HADS depression subscale score ≥ 10, HDRS ≥ 16 Fluoxetine versus. paroxetine FU: 12 wk Depression: HDRS:…”
BackgroundInfluentialIntegration of behavioral health and primary care: current knowledge and future directions
Vogel, M. E., Kanzler, K. E., Aikens, J. E., & Goodie, J. L. (2017) · Journal of Behavioral Medicine · doi:10.1007/s10865-016-9798-7 · Cited by 96
“Johnson et al. (2014) conducted a pragmatic controlled implementation trial examining the efficacy of a nurse case-manager-based approach to patients with depression and Type 2 diabetes.”
Backgroundde Groot, M., Shubrook, J. H., Hornsby, W. G., Pillay, Y., Mather, K. J., Fitzpatrick, K., Yang, Z., & Saha, C. (2019) · Diabetes Care · doi:10.2337/dc18-2400 · Cited by 56
Wozniak, L., Soprovich, A., Rees, S., Al Sayah, F., Majumdar, S. R., & Johnson, J. A. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.05.004 · Cited by 36
Self-citationThe role of relapse prevention for depression in collaborative care: a systematic review
Moriarty, A. S., Coventry, P. A., Hudson, J. L., Cook, N., Fenton, O. J., Bower, P., Lovell, K., Archer, J., Clarke, R., Richards, D. A., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.105 · Cited by 35
Metadata
- Authors
- Johnson, J. A., Al Sayah, F., Wozniak, L., Rees, S., Soprovich, A., Qiu, W., Chik, C. L., Chue, P., Florence, P., Jacquier, J., Lysak, P., Opgenorth, A., Katon, W., & Majumdar, S. R.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-11-08
- Volume
- 37
- Issue
- 12
- Pages
- 3220-3226
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2097922628
- Cited by
- 72
- References
- 10
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Collaborative Care Versus Screening and Follow-up for Patients With Diabetes and Depressive Symptoms: Results of a Primary Care–Based Comparative Effectiveness Trial. https://app.cochat.ai/papers/10.2337/dc14-1308
- The paper
- Johnson, J. A., Al Sayah, F., Wozniak, L., Rees, S., Soprovich, A., Qiu, W., Chik, C. L., Chue, P., Florence, P., Jacquier, J., Lysak, P., Opgenorth, A., Katon, W., & Majumdar, S. R. (2014). Collaborative Care Versus Screening and Follow-up for Patients With Diabetes and Depressive Symptoms: Results of a Primary Care–Based Comparative Effectiveness Trial. Diabetes Care. https://doi.org/10.2337/dc14-1308
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.